What is the ROCE (Return on Capital Employed) of Neuronetics this year?
The ROCE of Neuronetics is -0.89 undefined this year.
Neuronetics ROCE 2024
Neuronetics ROCE
-0.89
Neuronetics Dividend yield
Ticker
STIM
ISIN
US64131A1051
WKN
A2JPMY
In 2024, Neuronetics's return on capital employed (ROCE) was -0.89, a 45.34% increase from the -0.61 ROCE in the previous year.
Neuronetics Aktienanalyse
What does Neuronetics do?
Neuronetics Inc is a globally leading company in the field of non-invasive neuromodulatory technology. It was founded in 2003 and is headquartered in Malvern, Pennsylvania. The company specializes in the development and production of transcranial magnetic stimulation devices that can be used in the treatment of psychiatric disorders, particularly severe depression. Neuronetics' business model is based on selling its patented technology, called NeuroStar Advanced Therapy, to medical facilities worldwide. The company works closely with leading psychiatrists and clinical neurophysiologists to ensure that their devices meet the highest quality standards and can provide the best possible help to patients. The company has achieved a number of significant milestones in recent years. For example, in 2008, it received the first FDA approval for its technology. Since then, Neuronetics has continuously developed and improved its technology and has also obtained approvals in Europe and other parts of the world. Neuronetics is divided into various divisions, including research and development, manufacturing, and sales. Each of these departments is focused on ensuring the highest quality standards and ensuring that the technology of NeuroStar Advanced Therapy meets the needs of patients and medical personnel. The technology of NeuroStar Advanced Therapy is based on transcranial magnetic stimulation (TMS), which uses gentle magnetic fields to stimulate the activity of certain brain regions. The stimulation can help restore the balance of neurotransmitters in the brain and thus alleviate depression. Treatment with NeuroStar Advanced Therapy has significant advantages over conventional antidepressant medications. In many cases, it leads to faster improvement of symptoms and does not cause any of the undesirable side effects that can occur with medication. Overall, Neuronetics has developed a revolutionary technology with NeuroStar Advanced Therapy that can help millions of people around the world overcome their depression. The company is proud to contribute to improving the quality of life for people and will continue to develop innovative solutions in the field of neuromodulatory technology in the future. Neuronetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Neuronetics's Return on Capital Employed (ROCE)
Neuronetics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Neuronetics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Neuronetics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Neuronetics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Neuronetics Stock
How has the ROCE (Return on Capital Employed) of Neuronetics developed compared to the previous year?
The ROCE of Neuronetics has increased by 45.34% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Neuronetics?
A high Return on Capital Employed (ROCE) indicates that Neuronetics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Neuronetics?
A low ROCE (Return on Capital Employed) can indicate that Neuronetics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Neuronetics impact the company?
An increase in the ROCE of Neuronetics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Neuronetics affect the company?
A decrease in ROCE of Neuronetics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Neuronetics?
Some factors that can affect Neuronetics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Neuronetics so important for investors?
The ROCE of Neuronetics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Neuronetics take to improve the ROCE?
To improve the ROCE, Neuronetics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Neuronetics pay?
Over the past 12 months, Neuronetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Neuronetics is expected to pay a dividend of 0 USD.
What is the dividend yield of Neuronetics?
The current dividend yield of Neuronetics is .
When does Neuronetics pay dividends?
Neuronetics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Neuronetics?
Neuronetics paid dividends every year for the past 0 years.
What is the dividend of Neuronetics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Neuronetics located?
Neuronetics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Neuronetics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Neuronetics from 5/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.
When did Neuronetics pay the last dividend?
The last dividend was paid out on 5/23/2024.
What was the dividend of Neuronetics in the year 2023?
In the year 2023, Neuronetics distributed 0 USD as dividends.
In which currency does Neuronetics pay out the dividend?
The dividends of Neuronetics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Neuronetics
Our stock analysis for Neuronetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neuronetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
